Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

Birgit Gruenberger, Johannes Schueller, Ute Heubrandtner, Fritz Wrba, Dietmar Tamandl, Klaus Kaczirek, Sandra Freimann-Pircher, Thomas Gruenberger

The Lancet Oncology · 2010 · 244 citations · 32 references

Concepts

References

32